BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ponziani FR, Zocco MA, Senzolo M, Pompili M, Gasbarrini A, Avolio AW. Portal vein thrombosis and liver transplantation: Implications for waiting list period, surgical approach, early and late follow-up. Transplant Rev (Orlando). 2014;28:92-101. [PMID: 24582320 DOI: 10.1016/j.trre.2014.01.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Senzolo M, Garcia-Tsao G, García-Pagán JC. Current knowledge and management of portal vein thrombosis in cirrhosis. J Hepatol 2021;75:442-53. [PMID: 33930474 DOI: 10.1016/j.jhep.2021.04.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
2 Turon F, Hernández-Gea V, García-Pagán JC. Portal vein thrombosis: yes or no on anticoagulation therapy. Curr Opin Organ Transplant 2018;23:250-6. [PMID: 29432256 DOI: 10.1097/MOT.0000000000000506] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
3 Blasi A, Hernandez V, Fernandez J, Colmenero J, Beltran J, Garcia-Valdecasas JC, Reverter JC. Venous Thrombotic Events After Liver Transplantation. Clin Appl Thromb Hemost 2018;24:317-22. [PMID: 27899521 DOI: 10.1177/1076029616680477] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
4 Gomez Gavara C, Bhangui P, Salloum C, Osseis M, Esposito F, Moussallem T, Lahat E, Fuentes L, Compagnon P, Ngongang N, Lim C, Azoulay D. Ligation versus no ligation of spontaneous portosystemic shunts during liver transplantation: Audit of a prospective series of 66 consecutive patients. Liver Transpl 2018;24:505-15. [DOI: 10.1002/lt.24999] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
5 Sanchez-Ocaña R, Tejedor-Tejada J, Cimavilla-Roman M, de Benito-Sanz M, Asensio-Diaz E, Barrera-Rebollo A, Perez-Saborido B, Garcia-Pajares F, Almohalla-Alvarez C, Sanchez-Antolin G. Utility of Oral Anticoagulants as Prophylaxis of Recurrent Portal Thrombosis after Liver Transplantation. Transplant Proc 2019;51:83-6. [PMID: 30655140 DOI: 10.1016/j.transproceed.2018.07.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Stine JG, Wang J, Shah PM, Argo CK, Intagliata N, Uflacker A, Caldwell SH, Northup PG. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study. Liver Int. 2018;38:94-101. [PMID: 28632958 DOI: 10.1111/liv.13500] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 10.5] [Reference Citation Analysis]
7 Wan YM, Li YH, Wu HM, Xu ZY, Xu Y, Yang LH, Wu XN, Yang JH. Portal vein thrombosis before and after transjugular intrahepatic portosystemic shunt placement: An observational study (STROBE compliant). Medicine (Baltimore) 2017;96:e8498. [PMID: 29137043 DOI: 10.1097/MD.0000000000008498] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Mori A, Iida T, Iwasaki J, Ogawa K, Fujimoto Y, Uemura T, Hatano E, Okajima H, Kaido T, Uemoto S. Portal vein reconstruction in adult living donor liver transplantation for patients with portal vein thrombosis in single center experience. J HepatobiliaryPancreatSci. 2015;22:467-474. [PMID: 25755116 DOI: 10.1002/jhbp.235] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
9 Pardo F, Pons JA, Briceño J. V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante. Gastroenterología y Hepatología 2015;38:600-18. [DOI: 10.1016/j.gastrohep.2015.06.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Safwan M, Nagai S, Abouljoud M. Portal Vein Inflow From Enlarged Coronary Vein in Liver Transplantation. Transplantation Proceedings 2016;48:3070-2. [DOI: 10.1016/j.transproceed.2016.05.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
11 Stine JG, Argo CK, Pelletier SJ, Maluf DG, Caldwell SH, Northup PG. Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis. World J Hepatol 2017; 9(3): 139-146 [PMID: 28217250 DOI: 10.4254/wjh.v9.i3.139] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
12 Lopez-Gomez M, Llop E, Puente A, Hernández Conde M, Ruiz P, Alvárez S, Martínez JL, Abad J, Fernández N, Perelló C, Fernández-Carrillo C, Ferre C, Trapero M, Fraga E, Crespo J, Calleja Panero JL. Non-malignant portal vein thrombosis in a cohort of cirrhotic patients: Incidence and risk factors. Hepatol Res 2021. [PMID: 34324766 DOI: 10.1111/hepr.13703] [Reference Citation Analysis]
13 Franzoni LC, Carvalho FC, Garzon RGA, Yamashiro FDS, Augusti L, Santos LAA, Dorna MS, Baima JP, Lima TB, Caramori CA, Silva GF, Romeiro FG. Embolization of splenorenal shunt associated to portal vein thrombosis and hepatic encephalopathy. World J Gastroenterol 2014; 20(42): 15910-15915 [PMID: 25400477 DOI: 10.3748/wjg.v20.i42.15910] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
14 Ponziani FR, Zocco MA, Cerrito L, Gasbarrini A, Pompili M. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications. Expert Rev Gastroenterol Hepatol. 2018;12:641-656. [PMID: 29806487 DOI: 10.1080/17474124.2018.1481747] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 14.0] [Reference Citation Analysis]
15 del Carmen Manzano-robleda M, Barranco-fragoso B, Uribe M, Méndez-sánchez N. Portal vein thrombosis: What is new? Annals of Hepatology 2015;14:20-7. [DOI: 10.1016/s1665-2681(19)30797-5] [Cited by in Crossref: 34] [Article Influence: 5.7] [Reference Citation Analysis]
16 Stine JG, Shah NL, Argo CK, Pelletier SJ, Caldwell SH, Northup PG. Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis. Liver Transpl. 2015;21:1016-1021. [PMID: 25845711 DOI: 10.1002/lt.24134] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 12.2] [Reference Citation Analysis]
17 Stine JG, Northup PG. Coagulopathy Before and After Liver Transplantation: From the Hepatic to the Systemic Circulatory Systems. Clin Liver Dis 2017;21:253-74. [PMID: 28364812 DOI: 10.1016/j.cld.2016.12.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
18 Chen H, Turon F, Hernández-Gea V, Fuster J, Garcia-Criado A, Barrufet M, Darnell A, Fondevila C, Garcia-Valdecasas JC, Garcia-Pagán JC. Nontumoral portal vein thrombosis in patients awaiting liver transplantation. Liver Transpl 2016;22:352-65. [PMID: 26684272 DOI: 10.1002/lt.24387] [Cited by in Crossref: 54] [Cited by in F6Publishing: 39] [Article Influence: 10.8] [Reference Citation Analysis]
19 Faccia M, Ainora ME, Ponziani FR, Riccardi L, Garcovich M, Gasbarrini A, Pompili M, Zocco MA. Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate. World J Gastroenterol 2019; 25(31): 4437-4451 [PMID: 31496623 DOI: 10.3748/wjg.v25.i31.4437] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
20 Xue Z, Zhang X, Li Z, Deng R, Wu L, Ma Y. Analysis of portal vein thrombosis after liver transplantation. ANZ Journal of Surgery 2019;89:1075-9. [DOI: 10.1111/ans.15242] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Pardo F, Pons JA, Briceño J. V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante. Cirugía Española 2015;93:619-37. [DOI: 10.1016/j.ciresp.2015.04.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
22 Bert J, Geerts A, Vanlander A, Abreu de Carvalho L, Degroote H, Berrevoet F, Rogiers X, van Vlierberghe H, Verhelst X. Up to 50% of portal vein thrombosis remains undiagnosed until liver transplantation. Clin Transplant 2020;34:e14107. [PMID: 33030231 DOI: 10.1111/ctr.14107] [Reference Citation Analysis]
23 Mikolasevic I, Filipec-Kanizaj T, Mijic M, Jakopcic I, Milic S, Hrstic I, Sobocan N, Stimac D, Burra P. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand? World J Gastroenterol 2018; 24(14): 1491-1506 [PMID: 29662288 DOI: 10.3748/wjg.v24.i14.1491] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 40] [Article Influence: 16.7] [Reference Citation Analysis]
24 Wang J, Chai JS, Zhang YM. Anticoagulation treatment of portal vein thrombosis in a patient with cirrhosis awaiting liver transplantation: A case report. Medicine (Baltimore) 2018;97:e11183. [PMID: 29952969 DOI: 10.1097/MD.0000000000011183] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
25 Agbim U, Jiang Y, Kedia SK, Singal AK, Ahmed A, Bhamidimarri KR, Bernstein DE, Harrison SA, Younossi ZM, Satapathy SK. Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis. Liver Transpl. 2019;25:68-78. [PMID: 30091296 DOI: 10.1002/lt.25322] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
26 Stine JG, Shah PM, Cornella SL, Rudnick SR, Ghabril MS, Stukenborg GJ, Northup PG. Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: A meta-analysis. World J Hepatol 2015; 7(27): 2774-2780 [PMID: 26644821 DOI: 10.4254/wjh.v7.i27.2774] [Cited by in Crossref: 66] [Cited by in F6Publishing: 53] [Article Influence: 11.0] [Reference Citation Analysis]
27 Dell’era A, Seijo S. Portal vein thrombosis in cirrhotic and non cirrhotic patients: from diagnosis to treatment. Expert Opinion on Orphan Drugs 2016;4:927-40. [DOI: 10.1080/21678707.2016.1215907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
28 von Köckritz L, De Gottardi A, Trebicka J, Praktiknjo M. Portal vein thrombosis in patients with cirrhosis. Gastroenterol Rep (Oxf) 2017;5:148-56. [PMID: 28533912 DOI: 10.1093/gastro/gox014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
29 Stine JG, Pelletier SJ, Schmitt TM, Porte RJ, Northup PG. Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients. HPB (Oxford). 2016;18:279-286. [PMID: 27017168 DOI: 10.1016/j.hpb.2015.10.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]